Ho N, Punturieri A, Wilkin D, Szabo J, Johnson M, Whaley J, Davis J, Clark A, Weiss S, Francomano C
Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
J Bone Miner Res. 1999 Oct;14(10):1649-53. doi: 10.1359/jbmr.1999.14.10.1649.
Pycnodyostosis, an autosomal recessive osteosclerosing skeletal disorder, has recently been shown to result from mutations in the cathepsin K gene. Cathepsin K, a lysosomal cysteine protease with an abundant expression in osteoclasts, has been implicated in osteoclast-mediated bone resorption and remodeling. DNA sequence analysis of the cathepsin K gene in a nonconsanguineous family demonstrated compound heterozygozity for mutations in two affected siblings. We have identified a missense mutation with a single base G-->A transition at cDNA nucleotide 236, resulting in conversion of a conserved glycine to a glutamine residue (G79E). The other mutation is an A-->T transition at nucleotide 154, leading to the substitution of a lysine residue by a STOP codon (K52X) predicting premature termination of the precursor cathepsin K polypeptide. Sequencing of genomic and cDNAs from the parents demonstrated that the missense mutation was inherited from the father and the nonsense mutation from the mother. Protein expression in both affected children was virtually absent, while in the parents was reduced by 50-80% compared with controls. The protein studies demonstrate that even significantly reduced cathepsin K levels do not have any phenotypic effect, whereas absent cathepsin K results in pycnodysostosis.
致密性成骨不全症是一种常染色体隐性遗传性骨硬化性骨骼疾病,最近研究表明它是由组织蛋白酶K基因的突变引起的。组织蛋白酶K是一种在破骨细胞中大量表达的溶酶体半胱氨酸蛋白酶,与破骨细胞介导的骨吸收和重塑有关。对一个非近亲家庭中的组织蛋白酶K基因进行DNA序列分析,发现两名患病同胞存在复合杂合性突变。我们鉴定出一个错义突变,在cDNA核苷酸236处发生单个碱基G→A转换,导致一个保守的甘氨酸转变为谷氨酰胺残基(G79E)。另一个突变是在核苷酸154处发生A→T转换,导致一个赖氨酸残基被一个终止密码子取代(K52X),这预测组织蛋白酶K前体多肽会提前终止。对父母的基因组和cDNA进行测序表明,错义突变来自父亲,无义突变来自母亲。两个患病孩子几乎都没有蛋白质表达,而父母的蛋白质表达与对照组相比降低了50 - 80%。蛋白质研究表明,即使组织蛋白酶K水平显著降低也没有任何表型效应,而缺乏组织蛋白酶K则会导致致密性成骨不全症。